2018-02645. Bulk Manufacturer of Controlled Substances Application: Noramco, Inc.  

  • Start Preamble

    ACTION:

    Notice of application.

    DATES:

    Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 10, 2018.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.

    In accordance with 21 CFR 1301.33(a), this is notice that on July 6, 2017, Noramco, Inc., 1440 Olympic Drive, Athens, Georgia 30601 applied to be registered as a bulk manufacturer for the basic classes of controlled substances:

    Controlled substanceDrug codeSchedule
    Cathinone1235I
    Gamma Hydroxybutyric Acid2010I
    Marihuana Extract7350I
    Marihuana7360I
    Tetrahydrocannabinols7370I
    Codeine-N-oxide9053I
    Dihydromorphine9145I
    Hydromorphinol9301I
    Morphine-N-oxide9307I
    Amphetamine1100II
    Lisdexamfetamine1205II
    Methylphenidate1724II
    Nabilone7379II
    Codeine9050II
    Dihydrocodeine9120II
    Oxycodone9143II
    Hydromorphone9150II
    Hydrocodone9193II
    Morphine9300II
    Oripavine9330II
    Thebaine9333II
    Opium tincture9630II
    Oxymorphone9652II
    Noroxymorphone9668II
    Alfentanil9737II
    Sufentanil9740II
    Carfentanil9743II
    Tapentadol9780II
    Fentanyl9801II

    The company plans to manufacture bulk active pharmaceutical ingredients (APIs) and reference standards for distribution to their customers.

    In reference to drug codes 7360 (marihuana) and 7370 (tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration.

    Start Signature

    Dated: January 31, 2018.

    Susan A. Gibson,

    Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2018-02645 Filed 2-8-18; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
02/09/2018
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2018-02645
Dates:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 10, 2018.
Pages:
5808-5808 (1 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2018-02645.pdf